p53及mdm2在脑膜瘤中的表达及意义
摘要
脑膜瘤是中枢神经系统常见肿瘤之一,其发生机制仍然不清楚,随着肿瘤分子生物学研究的进展,目前认为脑膜瘤的发生和发展与癌基因活化及抑癌基因失活有关,mdm2瘤基因产物过表达可能使脑膜瘤中野生性p53失活,p53和mdm2在脑膜瘤的发生发展中可能发挥协同作用。
出处
《国外医学(神经病学.神经外科学分册)》
2003年第5期408-410,共3页
Foreign Medical Sciences(Section On Neurology & Neurosurgery)
参考文献14
-
1George A, Younis BA, Raymond S, et al. Aggressive meningeal tumors. Neurosurg,1995, 82(1):17.
-
2Foster BA , Coffey HA, Morin MJ, et al . Pharmacological rescue of mutant p53 conformation and function. Science, 1999, 286(5449) :2507- 2510.
-
3Laronga C, Yang HY, Neal C, et al. Association of the cyclin-dependent kinase and 14 - 3 - 3 sigma negatively regulates cell cycle progression. J Boil Chem, 2000, 275(30):23106-23112.
-
4Oda E, Ohki R, Murasawa H, et al. Noxa, a BH3 - member of the bcl- 2 family and candidate mediator of p53 - indueed apoptosis. Science,2000, 288(5468) : 1053 - 1058.
-
5Janowska K, Kordek R, Biernat W, et al. Biologic heterogeneity of angiomatous meningiomas . Pol J Pathol, 1998, 49(4):279-284.
-
6Yakut T, Bekar A, Doygun M, et al. Evaluation of relationship between chromosome 22 and p.53 gene alterations and the subtype of meningiomas by the interphnse- FISH technique. Teratog Carcinog Mutsgen, 2002,22(3) :217 - 225.
-
7Verheijen FM, Sprong M, Kloosterman JM, et al. TP53 mutations in human meningiomas . Int J Biol Markers, 2002, 17(1):42-48.
-
8Nagashima G, Aoyagi M, Yamamoto M, et al. P53 overexpressions and proliferative potential in malignant meningiomas. Acta Neurochir (Wien), 1999, 141(1) :53 - 61.
-
9Busehmann T, Fuchs SY, Lee CG, et al. SUMO- 1 modification of MDM2 prevents its serf - ubiqultination and increse mdm2 ability to ubiqultionte p.53. Cell, 2000,101(7) :753 - 762.
-
10Xirodimas D, Saville MK, Edling C, et al . Diffiegent effects of p14ARF on the levels of ubiquitinated p53 and MDM2 in vivo. Oncogene, 2001,20:4912 -4913.
-
1杜金荣,薛玉华,陈卫,丛晶,徐晓红.增殖细胞核抗原、癌基因在肺癌的表达及其意义[J].哈尔滨医科大学学报,1997,31(5):377-379.
-
2郑兴国,孙运才.c-myc癌基因与肿瘤[J].宁波医学,1999,11(1):36-38. 被引量:1
-
3庄志明,马旭东.前列腺癌mTOR信号通路与表遗传学的研究进展[J].中华泌尿外科杂志,2009,30(7):501-503. 被引量:1
-
4杨晓峰.P53 与膀胱肿瘤[J].国外医学(泌尿系统分册),1997,17(3):123-125.
-
5程红蕾,王若雨.鼻咽癌相关基因研究进展[J].国际肿瘤学杂志,2013,40(9):662-665. 被引量:4
-
6刘振声,丁华野.喉癌ras癌基因产物P21免疫组化检测及其临床意义[J].中华耳鼻咽喉科杂志,1993,28(5):295-296. 被引量:2
-
7陈谦,黄勇,蔡彦卿.PTEN、Survivin及ET-1在绝经后子宫肌瘤中的表达研究[J].现代妇产科进展,2009,18(11):855-857. 被引量:1
-
8何大健,吴长清,黄云超,杨世华.乳腺癌干细胞分子特性及其治疗新策略[J].生命科学,2011,23(10):963-968. 被引量:3
-
9崔文,孔灵玲,高继发,梁贵华,范连杰,张波.应用RT-PCR技术检测人类甲状腺癌中ret癌基因活化的研究[J].泰山医学院学报,2000,21(3):176-178. 被引量:2
-
10邓文婷,王双乐.p53,p16,bcl-2,cox-2与鼻咽癌关系的研究进展[J].实用医学杂志,2010,26(10):1849-1851. 被引量:5